empagliflozin (Jardiance) 25 mg

DRUG3 trials

Sponsors

National Institute on Aging (NIA), Ain Shams University, Martin Blomberg Jensen

Conditions

Diabete MellitusEmpaglifozinGranuloma, Foreign-BodyHeart FailureHypoglycemic AgentsParaffinomaPhysiological Effects of DrugsRemodeling, Left Ventricle

Phase 1

Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production

CompletedNCT03852901

National Institute on Aging (NIA)Empaglifozin, Hypoglycemic Agents, Physiological Effects of Drugs +1

Start: 2019-03-28End: 2021-12-13Updated: 2022-08-02

Phase 2

Effect of Empagliflozin 10 vs 25 mg on LV Remodeling in Diabetic Patients With Anterior STEMI With Reduced LVEF

CompletedNCT07169981

Ain Shams UniversityDiabete Mellitus, Heart Failure, Remodeling, Left Ventricle

Start: 2023-07-12End: 2025-06-17Updated: 2025-09-12

The GranStone Trial

Not yet recruitingNCT07828002

Martin Blomberg JensenGranuloma, Foreign-Body, Paraffinoma

Start: 2026-09-01End: 2029-04-01Target: 100Updated: 2026-09-18